Mohamad Koubeissi, MD
Mohamad Zakaria Koubeissi, MD, MA, FAAN, FANA, FAES is Professor of Neurology, and Director of the Epilepsy Center at George Washington University in Washington, DC. Dr. Koubeissi earned his BS with Distinction in Mathematics (1995) and his MD (1999) from the American University of Beirut (AUB) in Lebanon. In 2020 he also earned a master’s degree in English literature. After his graduation from medical school, he spent a year as a postdoctoral research fellow at AUB before he pursued his clinical training in Medicine and Neurology at Upstate Medical University in Syracuse, NY (2000-2002), New York University in New York, NY (2002-2004), and in Epilepsy at Johns Hopkins University in Baltimore, MD (2004-2006). He was on faculty at Case Western Reserve University in Cleveland, OH for 6 years before he joined George Washington University in 2012. During, and after, his training, Dr. Koubeissi has started new lines of research projects in epilepsy. He has lectured on the medical and surgical treatment of intractable epilepsy all over the Unites States as well as in Europe, Latin America, and the Middle East. He has published 100 papers and edited four books on epilepsy. He directs the annual Epilepsy Board review Course and the world-renowned, live-streaming monthly Epilepsy Grand Rounds at GWU. He is a reviewer for a number of major journals. Among his awards, he is a Fellow of the AAN, ANA, and AES, and has earned numerous other honors, including the Innovation Award from the School of Engineering at Case Western in 2012, and is a member of the Golden Key International Honor Society. Dr. Koubeissi’s research on consciousness and epilepsy was featured in a National Geographic documentary that aired in November 2015 all over the world in more than 50 languages.
Financial relationships
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:SK Life SciencesTopic:Speakers' BureauDate added:Date updated:05/10/2021
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:Sunovion PharmaceuticalsTopic:Speakers' BureauDate added:Date updated:05/10/2021
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:EisaiTopic:Speakers' BureauDate added:Date updated:05/10/2021